Malignant peripheral nerve sheath tumor epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
Line 12: Line 12:


==Age==
==Age==
* The incidence of malignant peripheral nerve sheath tumor increases with age.<ref name="pmid25130403">{{cite journal| author=Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS| title=Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. | journal=Pediatr Blood Cancer | year= 2014 | volume= 61 | issue= 11 | pages= 1955-60 | pmid=25130403 | doi=10.1002/pbc.25149 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25130403  }} </ref>
*Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally .<ref name="pmid25130403">{{cite journal| author=Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS| title=Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. | journal=Pediatr Blood Cancer | year= 2014 | volume= 61 | issue= 11 | pages= 1955-60 | pmid=25130403 | doi=10.1002/pbc.25149 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25130403  }} </ref>


==Gender==
==Gender==

Latest revision as of 14:16, 23 August 2019

Malignant peripheral nerve sheath tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Malignant peripheral nerve sheath tumor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Malignant peripheral nerve sheath tumor epidemiology and demographics

CDC on Malignant peripheral nerve sheath tumor epidemiology and demographics

Malignant peripheral nerve sheath tumor epidemiology and demographics in the news

Blogs on Malignant peripheral nerve sheath tumor epidemiology and demographics

Directions to Hospitals Treating Malignant peripheral nerve sheath tumor

Risk calculators and risk factors for Malignant peripheral nerve sheath tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]

Overview

Malignant peripheral nerve sheath tumors comprise ∼2% of all sarcomas whichare a small fraction of a group of cancers that affect 5 people per million per year. The incidence of malignant peripheral nerve sheath tumor is approximately 0.1 per 100,000 individuals worldwide.[1] The incidence of malignant peripheral nerve sheath tumor increases with age.[1] Malignant peripheral nerve sheath tumor affects men and women equally.[2]

Incidence

  • Malignant peripheral nerve sheath tumors comprise ∼2% of all sarcomas whichare a small fraction of a group of cancers that affect 5 people per million per year.
  • The incidence of malignant peripheral nerve sheath tumor is approximately 0.1 per 100,000 individuals worldwide.[1]
  • Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection.
  • Half of MPNSTs are associated with neurofibromatosis type 1 (NF1), the autosomal dominant condition that, affecting 1 in 3000 live births, represents the most common human cancer genetic predisposition syndrome.

Age

  • Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally .[1]

Gender

  • Malignant peripheral nerve sheath tumor may arise at any age with no gender predilection and affects men and women equally.[2]

References

  1. 1.0 1.1 1.2 1.3 Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS (2014). "Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population". Pediatr Blood Cancer. 61 (11): 1955–60. doi:10.1002/pbc.25149. PMID 25130403.
  2. 2.0 2.1 Malignant peripheral nerve sheath tumor. Radiopaedia 2015. http://radiopaedia.org/articles/malignant-peripheral-nerve-sheath-tumour

Template:WH Template:WS